Effect of dapagliflozin on visceral fat area in patients with type 2 diabetes

被引：0
|
作者：
Feng, Kun [1 ]
Huang, Hairu [1 ]
Fan, Lei [1 ]
Tang, Yingying [1 ]
Wang, Lingyu [1 ]
机构：
[1] Heilongjiang Prov Hosp Nangang Dist, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2019年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1504247
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EFFECT OF CANAGLIFLOZIN ON VISCERAL FAT AREA AND HEART RATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Mitsutake, Ryoko
    [J]. ATHEROSCLEROSIS, 2017, 263 : E252 - E252
  • [2] Association between thyroid hormones and visceral fat area in the patients with type 2 diabetes
    金庸
    [J]. China Medical Abstracts (Internal Medicine), 2020, 37 (02) : 74 - 74
  • [3] Effect of Dapagliflozin on Hepatic Fat, Visceral Fat and Hepatic Inflammatory Markers in Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes
    Phrueksotsai, Susrichit
    Thongsawat, Satawat
    Leerapun, Apinya
    Pinyopornpanish, Kanokwan
    Phrueksotsai, Juntima
    Phrommintikul, Arintaya
    Chattipakorn, Nipon
    Buranapin, Supawan
    [J]. HEPATOLOGY, 2018, 68 : 442A - 443A
  • [4] Visceral Fat Area, Not Subcutaneous Fat Area, is Associated with Cardiac Hemodynamics in Type 2 Diabetes
    Qiu, Yue
    Deng, Xia
    Sha, Yujing
    Wu, Xunan
    Zhang, Panpan
    Chen, Ke
    Zhao, Zhicong
    Wei, Weiping
    Yang, Ling
    Yuan, Guoyue
    Zhao, Li
    Wang, Dong
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 4413 - 4422
  • [5] The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease
    Phrueksotsai, Susrichit
    Pinyopornpanish, Kanokwan
    Euathrongchit, Juntima
    Leerapun, Apinya
    Phrommintikul, Arintaya
    Buranapin, Supawan
    Chattipakorn, Nipon
    Thongsawat, Satawat
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (10) : 2952 - 2959
  • [6] Use of Visceral Fat Area Measurement for Evaluating Obesity in Elderly Patients with Type 2 Diabetes
    Minamizuka, Takuya
    Maeda, Yukari
    Koshizaka, Masaya
    Ishikawa, Takahiro
    Maezawa, Yoshiro
    Yokote, Koutaro
    [J]. DIABETES, 2019, 68
  • [7] The Ratio of Visceral to Subcutaneous Fat Area Predicts Cardiovascular Events in Patients with Type 2 Diabetes
    Fukuda, Tatsuya
    Bouchi, Ryotaro
    Takeuchi, Takato
    Minami, Isao
    Izumiyama, Hajime
    Hashimoto, Koshi
    Yoshimoto, Takanobu
    Ogawa, Yoshihiro
    [J]. DIABETES, 2017, 66 : A112 - A112
  • [8] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    [J]. Journal of Nephrology, 2016, 29 : 391 - 400
  • [9] Effects of Dapagliflozin on Epicardial Fat Thickness in Patients with Type 2 Diabetes and Obesity
    Iacobellis, Gianluca
    Gra-Menendez, Silvia
    [J]. OBESITY, 2020, 28 (06) : 1068 - 1074
  • [10] Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
    Daniele, Giuseppe
    Xiong, Juan
    Solis-Herrera, Carolina
    Merovci, Aurora
    Eldor, Roy
    Tripathy, Devjit
    DeFronzo, Ralph A.
    Norton, Luke
    Abdul-Ghani, Muhammad
    [J]. DIABETES CARE, 2016, 39 (11) : 2036 - 2041
12345